Shanghai Haohai Biological Technology Co. Ltd (5HB) — Cash Flow-to-Debt Ratio
Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Cash Flow-to-Debt Ratio of 0.12x as of June 2023, meaning its operating cash flow of €141.99 Million could theoretically repay 0% of its total liabilities (€1.16 Billion) in one year. See 5HB financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Haohai Biological Technology Co. Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Shanghai Haohai Biological Technology Co. Ltd across 10 annual periods. For the full cash flow conversion analysis, see Shanghai Haohai Biological Technology Co (5HB) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Shanghai Haohai Biological Technology Co. Ltd (2016–2025)
Year-by-year debt coverage analysis for Shanghai Haohai Biological Technology Co. Ltd. Check 5HB operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | €490.97 Million | €1.12 Billion | ▼ -18.3% |
| 2024 | 0.54x | €648.57 Million | €1.20 Billion | ▼ -7.6% |
| 2023 | 0.58x | €634.45 Million | €1.09 Billion | ▲ +149.6% |
| 2022 | 0.23x | €231.30 Million | €990.02 Million | ▼ -39.2% |
| 2021 | 0.38x | €342.29 Million | €890.07 Million | ▼ -17.2% |
| 2020 | 0.46x | €262.07 Million | €564.46 Million | ▼ -33.7% |
| 2019 | 0.70x | €348.91 Million | €498.52 Million | ▲ +7.5% |
| 2018 | 0.65x | €391.28 Million | €600.90 Million | ▲ +34.5% |
| 2017 | 0.48x | €343.06 Million | €708.59 Million | ▲ +34.6% |
| 2016 | 0.36x | €254.49 Million | €707.55 Million | — |